Researchers are advancing a novel cell therapy approach for Type 1 diabetes, focusing on long-term islet cell durability without the need for immunosuppression.
Researchers have successfully derived functional retinal endothelial cells from human pluripotent stem cells, creating new avenues for vision restoration.